Humacyte, Inc.
No trades
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 2.04 M USD, the most of which — 2.04 M USD — came from its top-performing segment, Acellular Human Tissues, compared to 1.56 M USD the previous year. The greatest contribution came from United States, which accounted for 2.04 M USD last year, with 1.56 M USD the year before.
By source
By country